Healthcare · Hepatitis B prevalence

Hepatitis B prevalence in USA in 2026

Hepatitis B prevalence in the United States is just 0.1 %—one of the lowest rates globally, corresponding to 1-th place out of 197. This success is driven by universal newborn vaccination, introduced in 1991, and screening programs for pregnant women. Chronic carriers are mostly immigrants from Asia and Africa, where the virus is endemic. The native-born population, thanks to immunization, rarely encounters this infection.

Data for 2026 · unit: %
Position

USA world ranking

#1 / 197

Country position on the scale from last to first place for this indicator.

US
#1
#197#1
Trend

Change over time

Change in indicator over the available period.

0.3
1990
0.2
2000
0.1
2010
0.1
2020
0.1
2026

Values — %

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Hepatitis B prevalence in USA — how much?
Based on 2026 data — 0.1 %. This is rank #1 out of 197 countries.
What is USA's rank by Hepatitis B prevalence?
USA ranks #1 out of 197 countries in the world ranking by «Hepatitis B prevalence».
How has Hepatitis B prevalence changed in USA?
Over the available period the indicator changed from 0.3 to 0.1 %.